PADCEV Copay Assistance Program

The PADCEV Copay Assistance Programa (Program) is for eligible patients who have private commercial health insurance and are not insured by any federal or state healthcare program, including, but not limited to, Medicare, Medicaid, TRICARE, or Veterans Affairs (VA). Under this Program:

  • Patients may pay as little as $5 per dose
  • A patient will be enrolled in the Program for a 12-month period
  • Patients may save up to a maximum of $25,000 per calendar year
  • There are no income requirements

Enrolling Patients in the PADCEV Copay Assistance Program

PADCEV Support Solutions can evaluate eligibility and enroll patients in the PADCEV Copay Assistance Program.

For more information, contact us at 1‑888‑402‑0627. We are available Monday–Friday, 8:30 am–8:00 pm ET.

PADCEV Support Solutions is a component of Astellas Pharma Support SolutionsSM. Contact PADCEV Support Solutions for enrollment information at 1‑888‑402‑0627.

aBy enrolling in the PADCEV Copay Assistance Program ("Program"), the patient acknowledges that they currently meet the eligibility criteria and will comply with the following terms and conditions: The Program is for eligible patients with commercial prescription insurance for PADCEV® (enfortumab vedotin-ejfv) and is good for use only with a valid prescription for PADCEV. The Program has an annual maximum copay assistance limit of $25,000 per calendar year. After the annual maximum on copay assistance is reached, patient will be responsible for the remaining out-of-pocket costs for PADCEV. The Program is not valid for patients insured by any state or federal healthcare program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program. Patients who move from commercial insurance to federal or state prescription health insurance will no longer be eligible, and agree to notify the Program of any such change. This offer is not valid for cash paying patients. Patients agree not to seek reimbursement from any health insurance or third party for all or any part of the benefit received by the patient through the Program. This offer is not conditioned on any past, present, or future purchase of PADCEV. This offer is not transferrable, has no cash value, and cannot be combined with any other offer, free trial, prescription savings card, or discount. The full value of the Program benefits is intended to pass entirely to the eligible patient. The benefit available under this Program is valid only for the patient's out-of-pocket medication costs for PADCEV. The benefit is not valid for any other out-of-pocket costs such as medication administration charges or other healthcare provider services. No other individual or entity (including, without limitation, third party payers, pharmacy benefit managers, or the agents of either) is entitled to receive any benefit, discount, or other amount in connection with this Program. This offer is not health insurance and is only valid for patients in the 50 United States, Washington DC, and Puerto Rico. This Program is void where prohibited by law. No membership fees. Certain rules and restrictions apply. Astellas reserves the right to revoke, rescind, or amend this offer without notice for any reason (including to ensure that the offer is utilized solely for the patient's benefit).

PADCEV® and the PADCEV device are trademarks jointly owned by Agensys, Inc., and Seagen Inc.